Skip to main content
. 2018 Mar 30;22(7):3423–3433. doi: 10.1111/jcmm.13619

Figure 5.

Figure 5

CRB3 inhibits β‐catenin signalling. (A) Western blot analysis of β‐catenin, CD44, cMyc, OCT4 and NANOG expression in CRB3‐overexpressing and CRB3‐knockdown cells. (B) Real‐time PCR analysis of CD44, cMyc and NANOG in CRB3‐overexpressing and CRB3‐knockdown cells. (C) Immunofluorescence analysis of β‐catenin localization is shown. Statistical significance was calculated using unpaired t test (B)